Try our Advanced Search for more refined results
In re Xenoport, Inc. Securities Litigation
Case Number:
5:10-cv-03301
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
-
May 23, 2011
XenoPort Investors' Horizant Suit Tossed For Now
A federal judge in California on Friday tossed a shareholder class action against XenoPort Inc., saying claims that the company withheld information about problems delaying the approval of restless legs syndrome drug Horizant weren't sufficient and needed to be redrawn.
-
January 05, 2011
Shareholders Join Suits In XenoPort Stock Price Case
XenoPort Inc. shareholders have lodged a consolidated class action based on two earlier suits claiming the company withheld information that caused federal regulators to block approval of a restless leg syndrome drug it developed with GlaxoSmithKline PLC, allegedly inflating share prices.